Evaluation of the effects of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non‐alcoholic fatty liver disease

达帕格列嗪 瞬态弹性成像 脂肪变性 内科学 脂肪肝 胃肠病学 医学 2型糖尿病 纤维化 安慰剂 糖尿病 内分泌学 肝纤维化 病理 疾病 替代医学
作者
Masanori Shimizu,Kunihiro Suzuki,Kanako Kato,Teruo Jojima,Toshie Iijima,Toshimitsu Murohisa,Makoto Iijima,Hidehiro Takekawa,Isao Usui,Hideyuki Hiraishi,Yoshimasa Aso
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
卷期号:21 (2): 285-292 被引量:305
标识
DOI:10.1111/dom.13520
摘要

Aims To investigate the effects of dapagliflozin on liver steatosis and fibrosis evaluated in patients with type 2 diabetes and non‐alcoholic fatty liver disease (NAFLD). Materials and methods In a randomized, active‐controlled, open‐label trial, 57 patients with type 2 diabetes and NAFLD were randomized to a dapagliflozin group (5 mg/d; n = 33) or a control group (n = 24) and were treated for 24 weeks. Hepatic steatosis and fibrosis were assessed using transient elastography to measure controlled attenuation parameter (CAP) and liver stiffness, respectively. Results Baseline liver stiffness measurement (LSM) was positively correlated with several markers and scoring systems for liver fibrosis. In week 24, there was a significant decrease in CAP from 314 ± 61 to 290 ± 73 dB/m ( P = 0.0424) in the dapagliflozin group, while there was no significant change in the control group. In addition, LSM tended to decrease from 9.49 ± 6.05 to 8.01 ± 5.78 kPa in the dapagliflozin group. In 14 patients from this group with LSM values ≥8.0 kPa, indicating significant liver fibrosis, LSM decreased significantly from 14.7 ± 5.7 to 11.0 ± 7.3 kPa ( P = 0.0158). Furthermore, serum alanine aminotransferase and γ‐glutamyltranspeptidase levels decreased in the dapagliflozin group, but not in the control group, and visceral fat mass was significantly reduced in the dapagliflozin group. Conclusions Based on these findings, the sodium‐glucose co‐transporter‐2 inhibitor dapagliflozin improves liver steatosis in patients with type 2 diabetes and NAFLD, and attenuates liver fibrosis only in patients with significant liver fibrosis, although the possibility cannot be excluded that a reduction in body weight or visceral adipose tissue by dapagliflozin may be associated with a decrease of liver steatosis or fibrosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
周翔完成签到,获得积分20
1秒前
大模型应助超人会飞233采纳,获得10
1秒前
meng发布了新的文献求助10
2秒前
Brocade发布了新的文献求助10
2秒前
2秒前
3秒前
Re发布了新的文献求助10
4秒前
我是老大应助galaxy采纳,获得10
4秒前
4秒前
4秒前
入骨发布了新的文献求助10
4秒前
SCIAI应助缥缈耷采纳,获得20
5秒前
赘婿应助yy123采纳,获得10
5秒前
秋秋发布了新的文献求助10
6秒前
科研通AI5应助kaka123采纳,获得30
6秒前
芭乐完成签到,获得积分10
7秒前
科研通AI2S应助加油科研采纳,获得10
8秒前
烟花应助TomatoPan采纳,获得10
8秒前
Hello应助落后的哈密瓜采纳,获得10
8秒前
9秒前
CodeCraft应助cadnash采纳,获得10
9秒前
Sean发布了新的文献求助10
9秒前
9秒前
9秒前
娃娃鱼完成签到,获得积分10
10秒前
10秒前
科目三应助十七采纳,获得10
10秒前
舒心的万声完成签到,获得积分10
10秒前
11秒前
欧阳欢完成签到,获得积分10
12秒前
脑洞疼应助戴岱采纳,获得10
12秒前
小羊枣泥发布了新的文献求助10
13秒前
13秒前
嘿嘿发布了新的文献求助10
13秒前
鲜于枫发布了新的文献求助30
13秒前
Brocade完成签到,获得积分10
14秒前
14秒前
15秒前
入骨完成签到,获得积分20
15秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3970172
求助须知:如何正确求助?哪些是违规求助? 3514982
关于积分的说明 11176568
捐赠科研通 3250212
什么是DOI,文献DOI怎么找? 1795198
邀请新用户注册赠送积分活动 875702
科研通“疑难数据库(出版商)”最低求助积分说明 805004